Targeting the Wnt pathway in zebrafish as a screening method to identify novel therapeutic compounds.

Abstract excerpt

Activating mutations in the Wnt signaling pathway account for the initiation of greater than 90% of all colorectal cancers and this pathway has been implicated in numerous other diseases. Therefore, identifying small molecule inhibitors of this pathway is of critical importance towards identifying clinically relevant drugs. Numerous screens have been employed to identify therapeutic reagents, but none have made...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Drug Evaluation, Preclinical
• Share to Embryo, Nonmammalian